Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 154 | 295 | 374 | 501 | 740 |
| TOTAL | $154 | $295 | $374 | $501 | $740 |
| Non-Current Assets | |||||
| Intangibles | 80 | 76 | 74 | 68 | 68 |
| TOTAL | $80 | $76 | $74 | $68 | $68 |
| Total Assets | $234 | $371 | $449 | $568 | $808 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,076 | 1,464 | 803 | 1,619 | 1,313 |
| Other current liabilities | 53 | 39 | 37 | 116 | 22 |
| TOTAL | $4,294 | $3,668 | $2,998 | $5,329 | $4,887 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 33 | 51 | 80 | 12 | 51 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,294 | $3,668 | $2,998 | $5,329 | $4,887 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 130,596 | 123,502 | 123,014 | 111,496 | 110,841 |
| Common Shares | 124 | 123 | 123 | 111 | 111 |
| Retained earnings | -12,003 | -11,227 | -10,412 | -10,288 | -9,666 |
| Other shareholders' equity | -624 | -591 | -540 | -460 | -448 |
| TOTAL | $-4,061 | $-3,297 | $-2,549 | $-4,761 | $-4,079 |
| Total Liabilities And Equity | $234 | $371 | $449 | $568 | $808 |